CAS 1235449-52-1

BEBT-908

CAS: 1235449-52-1

BEBT-908

Pureza: ≥98%

Peso molecular: 507.57g/mol

Ref: 54-BUP09236

BEBT-908

CAS: 1235449-52-1

BEBT-908 (PI3Kα inhibitor 1) is a selective PI3Kα inhibitor (IC50 <0.1 μM). BEBT-908 also inhibits HDAC (0.1 μM≤IC50≤1 μM).

Fórmula: C₂₃H₂₅N₉O₃S

Pureza: 99.67%

Forma y color: Solid

Peso molecular: 507.57

Ref: TM-T16529

BEBT-908

CAS: 1235449-52-1

BEBT-908 is a potent inhibitor of the cell cycle that inhibits the proliferation of fibroblasts by blocking G1 phase and inducing apoptosis. BEBT-908 has been shown to have synergistic effects with other drugs, such as paclitaxel, cisplatin, or etoposide. It also exhibits cytotoxicity against cutaneous malignant cells in a dose-dependent manner. This drug has been hypothesized to have pharmacologic effects on extracellular matrix production and growth factor production.!--

Fórmula: C₂₃H₂₅N₉O₃S

Pureza: Min. 95%

Peso molecular: 507.57 g/mol

Ref: 3D-KZB44952